Genotypic diversity of Mycobacterium tuberculosis in Pretoria
|
|
- Lora Phebe Owens
- 6 years ago
- Views:
Transcription
1 Genotypic diversity of Mycobacterium tuberculosis in Pretoria P Hove, J Molepo, S Dube, M Nchabeleng Prisca Hove, HBMLS, MSc(Med)Micro, Postgraduate Student Julitha Molepo, NDMedTech, BSc (Hons), MSc, PhD, Senior Scientist Samukeliso Dube, MBCHB, MPH, Senior Lecturer, Research Physician Maphoshane Nchabeleng, MBChB, MMed(Micro), Dip HIVMan, Postgrad Diploma(Inf PrevControl), Head of Department Department of Microbiological Pathology, University of Limpopo (Medunsa Campus) molepo@ul.ac.za Keywords: molecular epidemiology, spoligotyping, Mycobacterium tuberculosis, drug susceptibility, genotypic diversity, Pretoria Tuberculosis is a global health problem. Continuous efforts are needed to understand the genetic diversity and geographical distribution of Mycobacterium tuberculosis. The objective of this study was to determine the genetic diversity of M. tuberculosis strains in Soshanguve, Pretoria. Eighty-nine isolates that were sputum culture-positive in Mycobacterium Growth Indicator Tube 960, and positively identified by Accuprobe Probe assay as M. tuberculosis complex, were used in the study. The samples were sub-cultured on Lowenstein-Jensen (L-J) slants to ensure purity. Spoligotyping was performed, with slight modifications according to the manufacturer s specifications. Genotypic data were compared to the international spoligotyping database 4 (SpolDB4) and that suggested by Streicher et al. Spoligotyping identified 12 genotypes. Of the 89 isolates studied, 75 could be grouped into 11 clusters. The Beijing genotype family formed the largest group, with 21 isolates (28%). The remaining isolates were distributed among the Latino-American-Mediterranean (LAM) family: LAM3 (13%), LAM4 (4%), LAM9 (3%); the T family: T1 (23%), T2 (9%), and T3 (3%); the S family (8%); the X3 family (4%); CAS1-KILI (3%); and LAM11-ZWE (3%). Fourteen (16%) of the isolates had spoligotypes that did not match any of the spoligotype patterns deposited in the SpolDB4 database. Beijing was the most common genotype family, identified in 28% of the cases, followed by T1 (23%). The high prevalence of Beijing and T1 in this study reflects transmission of these genotype families within this community. The results of this study showed the dire need for more robust prevention strategies in tuberculosis control programmes. Other genotyping methods with a higher discriminatory power, such as restriction fragment length polymorphism, will be useful in defining the transmission patterns in this community. Peer reviewed. (Submitted: Accepted: ) SAJEI 2012;27(2):77-83 Introduction Despite the availability, for over 50 years, of effective antibiotic treatment of tuberculosis, every 15 seconds someone dies of the disease. 1 The incidence of tuberculosis has escalated from less than 200/ persons per year in 1990, to more than 500/ persons per year in 2006 in Africa s human immunodeficiency virus (HIV) burdened regions, which include sub-saharan Africa. 2,3 South Africa is among the 22 highest burdened countries affected by tuberculosis, with a very high number of cases relative to the total population. 4 The population of South Africa makes up 0.7% of the world s population, and yet contributes 28% of the number of HIVpositive tuberculosis cases worldwide, and 33% of HIV-positive tuberculosis cases in Africa. 3 The incidence of tuberculosis in South Africa is estimated to be more than 940/ persons per year, while the mortality rate is estimated to be 135/ persons per year. 5 The World Health Organization 2008 report showed a mortality rate of 218/ persons per year, which is a serious cause for concern. The emergence of multidrug-resistant (MDR) tuberculosis and extensively drug-resistant (XDR) tuberculosis (defined as resistant to Isoniazid and Rifampicin, in addition to any fluoroquinolones, and at least one injectable antituberculosis drug), 6 has worsened tuberculosis morbidity and mortality. 2 Molecular epidemiological techniques, such as IS6110- based restriction fragment length polymorphism (RFLP) and spoligotyping used for typing Mycobacterium tuberculosis, have expanded our ability to investigate and understand the tuberculosis epidemic. 7 The use of the IS6110 RFLPtyping method for differentiating M. tuberculosis strains is well documented However, RFLP analysis is labourintensive, has poor inter-laboratory reproducibility, and requires weeks of incubation for sufficient quantities of deoxyribonucleic acid (DNA). Thus, time remains a limiting factor in obtaining a highly effective method for epidemiological surveys, and preventing the spreading of disease ;27(2)
2 Spoligotyping, a method for simultaneous detection and typing of M. tuberculosis complex bacteria, has been developed, and is used as a marker to study the phylogeny of the M. tuberculosis complex. 16 This technique has been described as a highly practical, fast, and precise polymerase chain reaction- (PCR) based method, which exploits the DNA polymorphism in the direct repeat (DR) region of M. tuberculosis complex strains. Strains vary in the number of DRs, and in the presence or absence of particular spacers. These advantages make it an ideal molecular epidemiological tool. 13 The discriminatory power of spoligotyping is reported to be lower than that of RFLP. 17 However, despite this limitation, spoligotyping remains an important tool in genotyping clinical isolates in different epidemiological settings. 18,19 The Beijing strain of M. tuberculosis, which is thought to be virulent, has been associated with drug resistance If these strains have an enhanced capacity to gain resistance, this will have serious consequences for the treatment of tuberculosis. It is relevant to know whether specific genotype families are overrepresented, and whether these strains are successfully transmitted within the community. The purpose of this study was to determine the genetic diversity of M. tuberculosis strains in Soshanguve, Pretoria. Method Sample collection Convenience sampling was carried out, and 89 consecutive M. tuberculosis isolates from sputum cultures were collected, regardless of patient type, from the Dr George Mukhari National Health Laboratory Services mycobacteriology laboratory between June-August 2008, and included in the study. The isolates were collected from Mycobacterium Growth Indicator Tube (MGIT) 960 tubes after positive identification as M. tuberculosis complex using Accuprobe assay (Gene-probe, San Diego, California, USA). The study was approved by the University of Limpopo (Medunsa Campus) research and ethics committee. The samples were recovered by subculturing 0.4 ml of the MGIT culture on L-J slants to rule out contamination, and to ensure the availability of samples for further testing. The samples were inoculated in duplicate to ensure maximum recovery. The slants were placed on their sides, such that the solid medium was covered by the MGIT culture, and incubated for 24 hours at 37ºC. The cultures were then incubated for up to six weeks, or until confluent growth was observed. Spoligotyping DNA was extracted from the M. tuberculosis isolates as previously described. 26 Spoligotyping was performed with slight modifications according to the manufacturer s instructions (Isogen Biosolutions, Ijsseltein, the Netherlands), and as previously described. 12 Briefly, the DR region of the tuberculosis genome was amplified using primers, DRa and DRb, and the amplified biotinylated products were hybridised to a set of 43 oligonucleotides covalently bound to a membrane. The hybridised PCR products were then incubated with a streptavidin-peroxidase conjugate, and the membrane was then exposed to chemiluminescence (Amersham Buster, Braunschweig, Germany), and exposed on an X-ray film (Amersham Hyperfilm ECL, Braunschweig, Germany) according to the manufacturer s instructions. The X-ray film was developed using standard photochemical procedures. DNA extracts of M. tuberculosis H37Rv and M. bovis BCG were used as controls. Drug susceptibility Susceptibility testing was carried out, using the Middlebrook 7H9 (Becton Dickinson, Johannesburg, South Africa) proportion method, according to the manufacturer s instructions, and Clinical and Laboratory Standards Institute guidelines. First-line drugs, Streptomycin, Rifampicin, Isoniazid and Ethambutol were tested. Statistical analyses All patients included in this study were classified into two groups, characterised by clustered and nonclustered M. tuberculosis isolates. A cluster was defined as two or more patients strains with identical genetic patterns, and patients strains with unmatched genetic profiles were considered to be nonclustered. If the isolate did not have a matching pattern in the SpolDB4, it was defined as an orphan. Clusters were assumed to have arisen from recent transmission, and the clustering rate was used to determine the amount of recent transmission in this population. 12 The patients strains with the same genetic pattern represented an epidemiologically linked cluster. The association between clustering and drug resistance was tested in a bivariate analysis in order to test for independent risk factors for recent transmission. The data were analysed using EPI Info version 6.0 and SPSS version 17.0 (SigmaStat, SPSS, Chicago, Illinois, USA). Results Spoligotyping Isolates were assigned to specific genotype families according to their spoligotype signature, using the SpolDB4 database. 27 The following 11 genotype families were identified: Beijing, T1, T2, T3, LAM3, LAM4, LAM9, LAM11-ZWE, CAS1-KILI, H1 and X3 (Table I). Fourteen (16%) of the patterns were orphans, one of which was classified as F15, 39 according to Streicher et al (Table II). Spoligotype clusters among the study population Of the 89 isolates studied, 75 could be grouped into 13 clusters. The Beijing genotype family formed the largest group, with 21 isolates (28% of the clustered isolates). The cluster sizes ranged from 2-21 patterns per cluster. The isolates were ;27(2)
3 Table I: Spoligotype clusters observed in the study population (n = 75) Spoligotype family n (%) clusters Spoligopattern SIT a LAM3 10 (13%) 33 Beijing 21 (28%) 1 T2 7 (9%) 52 S 6 (8%) 34 LAM9 2 (3%) T1 17 (23%) 53 X3 3 (4%) 92 LAM4 3 (4%) 60 CAS1-KILI 2 (3%) 21 T3 2 (3%) 37 LAM11-ZWE 2 (3%) 59 Unique 2 (3%) Orphan Total 75 a = shared international types Table II: Spoligopatterns of isolates with no match in the international spoligotyping database 4 n Spoligotype description binary SpolDB4 a Streicher et al 39 2 Not in SpolDB4 F15 a = international spoligotyping database 4 distributed among the Latino-American-Mediterranean (LAM) family: LAM3 (13%), LAM4 (4%), LAM9 (3%); the T family: T1 (23%), T2 (9%) and T3 (3%); the S family (8%); the X3 family (4%); CAS1-KILI (3%); and LAM11-ZWE (3%); and one cluster was an orphan (3%) (Table II). Drug susceptibility All isolates belonging to the LAM3, S, LAM9, X3, LAM4, CAS1-KILI and LAM11-ZWE families were susceptible to all drugs. Of the 21 isolates belonging to the Beijing family, two (10%) were resistant to Isoniazid (with one being monoresistant), one (5%) to Rifampicin, and three (14%) to Ethambutol. Only one (5%) of these isolates was MDRtuberculosis. In the T1 family, one (6%) of the 17 isolates was MDR-tuberculosis, one (6%) was resistant to Ethambutol, and one (6%) was resistant to Streptomycin. One of the two isolates belonging to T3 was resistant to Isoniazid, and both were resistant to Ethambutol. Seven isolates belonging to T2 had two (29%) resistant to Isoniazid, one (14%) resistant to Rifampicin, and two (29%) resistant to Ethambutol (Table I). Discussion The genotypic diversity of M. tuberculosis strains in an urban area of Soshanguve in Pretoria was described. The results of this study were compared with those of other South African studies where the distribution of M. tuberculosis genotypes was detailed. 20,25, ;27(2)
4 Table III: Drug susceptibility results among isolates belonging to different families Spoligotype family n (%) clusters S a I b R c E d LAM3 10 (13%) S S S S Beijing 21 (28%) S R (10%) R (5%) R (14%) T2 7 (9%) S R (29%) R (14%) R (29%) S 6 (8%) S S S S LAM9 2 (2.5%) S S S S T1 17 (22%) R (6%) R (6%) R (6%) R (6%) X3 3 (4%) S S S S LAM4 3 (4%) S S S S CAS1-KILI 2 (2.5%) S S S S T3 2 (2.5%) S R (50%) S R (100%) LAM11-ZWE 2 (2.5%) S S S S a = Streptomycin, b = Isonioazid, c = Rifampicin, d = Ethambutol, e = susceptible, f = resistant In the present study, the Beijing strain was found to be the most common genotype family, identified in 28% of cases. This finding is similar to that reported in several previous overseas and South African studies. 20,25 In a South African study by Nicol et al, 28 LAM3 was found to be the highest genotype (31%), followed by Beijing (23%). However, other studies have reported a lower Beijing strain prevalence In the Western Cape, the F11 strain has been found to be the dominant strain. 39 The high rate of Beijing genotype strains reported here poses a cause for concern, as this family is implicated in drug resistance and is reported to be highly virulent. 40 Most of the isolates in the study clustered into the Beijing family, and this association of the Beijing genotype with clustering suggests that these strains are being transmitted throughout the community. The results may have been overestimated due to the low discriminatory power of spoligotyping which was the only genotyping method used in this study. In this investigation, 89% of the isolates were grouped into clusters. The presence of this high clustering rate suggests that there is ongoing transmission in the study population, and these results are consistent with previous reports. 22,41 The clustering rate in the present study is considerably higher than that reported in a study conducted in Botswana, which had a clustering rate of approximately 42%, 42 although these investigators used RFLP, which has a higher discriminatory power, compared to spoligotyping. 17 Only five per cent of the 21 isolates belonging to the Beijing family were MDR-tuberculosis (see Table I), and this is in contrast to reports from previous studies, where a high association between drug resistance and the Beijing genotype was reported. 24,25,29,43 Marais et al 44 also found the Beijing strain to be overrepresented in children with drug-resistant tuberculosis in the Western Cape. In the present study, the Beijing genotype was found in ages ranging from years (data not shown). This is in contrast to studies from Vietnam and Russia, where the Beijing genotype was associated with a young age in adult studies, 33 suggesting a more recent spread. The T1 family was the second most common genotype family in the present study (23%). This result is in contrast to a report by a recent South African study, where drug-resistant isolates belonging to the T lineage occurred with the highest frequency in two provinces (32% and 40%). 45 In that study, the Beijing isolates accounted for 10.3% of the total number of isolates tested, and had the second most prevalent genotype after T1, which was in concordance with numbers reported in other studies. 27,46 The remaining isolates were distributed among the LAM family: LAM3 (13%), LAM4 (4%), LAM9 (3%); the T family: T1 (23%), T2 (9%), and T3 (3%); the S family (8%); the X3 family (4%); CAS1-KILI (3%); and LAM11-ZWE (3%). T2 had the fourth highest frequency in this study (9%). This strain was also found in a study in Cameroon patients with pulmonary tuberculosis 47 and in a study in Cape Town. 20 The LAM3 strain is widely distributed worldwide and has been implicated in the tuberculosis epidemic in South Africa, and particularly the Western Cape province. 48 LAM4 and LAM9 have been found previously in XDR-tuberculosis patients in South Africa, 25 and also in studies conducted in Zimbabwe, Zambia and the Western Cape, South Africa. 49 The limitation of this study was the sole use of the spoligotyping method for the genotyping of strains, which has been reported to have a low discriminatory power than that of RFLP. 17 If both methods were used, different results may have been obtained. Conclusion Beijing was the most common genotype family, identified in 28% of the cases, followed by T1 (23%). The high prevalence of Beijing and T1 in this study, and the high clustering rates, may reflect that there is ongoing transmission of ;27(2)
5 these genotype families within this community. However, a conclusion cannot be made due to the low discriminatory power of spoligotyping. If confirmatory genotyping methods, with a higher discriminatory power such as RFLP IS6110 were also used in the study, different results may have been obtained. The results of this study emphasise the need for continuous surveillance programmes to monitor tuberculosis control efforts, especially in tuberculosis- and HIV-endemic areas, such as the area that was studied. Acknowledgements The authors are thankful to Mr Tom Letswalo of the Microbiological Pathology Laboratory, National Health Laboratory Services, Dr George Mukhari Laboratory, Pretoria, for assistance in the collection of samples. The authors extend their thanks to Prof Rob Warren of the Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, and his team for providing guidance and resources for the spoligotyping. This work was supported in part by the Department of Medical Microbiological Pathology, University of Limpopo, Medunsa Campus. References 1. Dye C, Watt CJ, Bleed DM, et al. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA. 2005;293(22): Dye C. Global epidemiology of tuberculosis. Lancet. 2006;367(9514): Global tuberculosis control: Surveillance, planning, financing: the world health report World Health Organization. Geneva: WHO; 2009: 4. Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. World Health Organization. Geneva: WHO; Global tuberculosis control: surveillance, planning, financing: the world health report World Health Organization. Geneva: WHO; Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, MMWR Morb Mortal Wkly Rep. 2006;55(11): Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev. 2006;19(4): Beck-Sague C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. JAMA. 1992;268(10): Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrugresistant Mycobacterium tuberculosis. Ann Intern Med. 1992;117(3): Edlin BR, Tokars JL, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalised patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326(23): Coninx R, Mathieu C, Debacker M, et al. First-line tuberculosis therapy and drugresistant Mycobacterium tuberculosis in prisons. Lancet. 1992;353(9157): Drobniewski FA, Gibson A, Ruddy M, Yates MD. Evaluation and utilization as a public health tool of a national molecular epidemiological tuberculosis outbreak database within the United Kingdom from 1997 to J Clin Microbiol. 2003;41(5): Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4): Groenen PMA, Bunschoten AE, Van Soolingen D, Van Embden JDA. Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis: application for strain differentiation by a novel typing method. Mol Microbiol 1997;10(5): Hermans PWM, Van Soolingen D, Bik EM, et al. Insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains. Infect Immun 1997;59(8): Filliol, I, Driscoll JR, Van Soolingen D, et al. Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study. J Clin Microbiol 1997;41(5): Kremer K, Van Soolingen D, Frothingham R, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: Interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol. 1999;37(8): Bauer J, Andersen BA, Kremer K, Miorner H. Usefulness of spoligotyping to discriminate IS6110 low-copy-number Mycobacterium tuberculosis complex strains cultured in Denmark. J Clin Microbiol. 1999;37(8): Cronin EL, Churchyard GJ, Clayton T, et al. Risk factors for pulmonary mycobacterial disease in South African gold miners: A case-control study. Am J Resp Crit Care Med. 1999;159(1): Streicher EM, Warren RM, Kewley C, et al. Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. J Clin Microbiol 1999;42(2): Almeida D, Rodriques C, Ashavid TF, et al. High incidence of the Beijing genotype among multi-drug resistant isolates of Mycobacterium tuberculosis in a tertiary care centre in Mumbai, India. Clin Infect Dis. 2005;40(6): Cox HS, Kubica T, Doshetov D, et al. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia. Respir Res. 2005;6: Park YK, Shin S, Ryu S, et al. Comparison of drug resistance genotypes between Beijing and non-beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Methods. 2005;63(2): Tsolaki AG, Gagneux S, Pym AS, et al. Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol. 2005;43(7): Mlambo CK, Warren RM, Poswa X, et al. Genotypic diversity of extensively drugresistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis. 2005;12(1): Svastova P, Pavlik I, Bartos M. Rapid differentiation of Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis by amplification of insertion element IS901. Vet Med Czech. 2002;47: Brudey K, Driscoll JR, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 2006;6: Nicol MP, Sola C, February B, et al. Distribution of strain families of Mycobacterium tuberculosis causing pulmonary and extrapulmonary disease in hospitalized children in Cape Town, South Africa. J Clin Microbiol. 2005;43(11): Toungoussova OS, Sandven P, Mariandyshev AO, et al. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol. 2002;40(6): Drobniewski F, Balabanova Y, Ruddy M, et al. Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: Dominance of the Beijing strain family. Emerg Infect Dis. 2002;8(11): Glynn JR, Whiteley J, Bifani PJ, et al. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: A systematic review. Emerg Infect Dis. 2002;8(8): Lillebaek T, Andersen AB, Dirksen A, et al. Mycobacterium tuberculosis Beijing genotype. Emerg Infect Dis. 2003;9(12): Drobniewski F, Balabanova Y, Nikolayevsky V, et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA. 2005;293(22): Kruuner A, Danilovitsh M, Pehme L, et al. Tuberculosis as an occupational hazard for health care workers in Estonia. Int J Tuberc Lung Dis. 2001;5(2): Pfyffer GE, Strassle A, Van Gorkum T, et al. Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis. 2001;7(5): Mokrousov I, Filliol I, Legrand E, et al. Molecular characterization of multiple-drugresistant Mycobacterium tuberculosis isolates from northwestern Russia and analysis of rifampin resistance using RNA/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpob gene. Res Microbiol. 2002;153: Diel R, Schneider S, Meywald-Walter K, et al. Epidemiology of tuberculosis in Hamburg, Germany: Long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol. 2002;40(2): Borgdorff MW, De Haas P, Kremer K, Van Soolingen D. Mycobacterium tuberculosis Beijing genotype, the Netherlands. Emerg Infect Dis. 2003;9(10): Streicher EM, Victor TC, Van der Spuy G, et al. Spoligotype signatures in the Mycobacterium tuberculosis complex. J Clin Microbiol. 2007;45(1): Bifani P, Mathema BJ, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 2002;10(1): Verver S, Warren RM, Munch Z, et al. Transmission of tuberculosis in a high incidence urban community in South Africa. Int J Epid. 2002;33(2): Lockman S, Sheppard JD, Braden CR, et al. Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population based prospective study of 301 pulmonary tuberculosis patients. J Clin Microbiol. 2001;39(3): Li WM, Wang SM, Li CY, et al. Molecular epidemiology of Mycobacterium tuberculosis in China: a nationwide random survey in Int J Tuberc Lung Dis. 2000;9(12): ;27(2)
6 44. Marais BJ, Victor TC, Hesseling AC, et al. Beijing and Haarlem genotypes are overrepresented among children with drug resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol. 2006;44(10): Starvum R, Mphahlele M, Ovreas K, et al. High diversity of Mycobacterium tuberculosis genotypes in South Africa and preponderance of mixed infections among ST53 isolates. J Clin Microbiol. 2006;47(6): Niang, MN, De la Salmoniere YG, Samb A, et al. Characterization of M. tuberculosis strains from West African patients by spoligotyping. Microbes Infect. 1999;1(14): Niobe-Enyangoh SN, Kuaban C, Sorlin P, et al. Genetic diversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon. J Clin Microbiol. 2003;41(6): Victor TC, De Haas PEW, Jordan AM, et al. Molecular characteristics and global spread of Mycobacterium tuberculosis with a Western Cape F11 genotype. J Clin Microbiol 2003;42(2): Chihota V, Apers L, Mungofa S, et al. Predominance of a single genotype of Mycobacterium tuberculosis in regions of Southern Africa. Int J Tuberc Lung Dis. 2003;11(3):
High Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India
BRIEF REPORT High Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India Deepak Almeida, 1 Camilla Rodrigues, 2 Tester
More informationPrevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients
Journal of Infection (2006) 53, 331e336 www.elsevierhealth.com/journals/jinf Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients Parissa
More informationTransmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos
Transmissibility, virulence and fitness of resistant strains of M. tuberculosis CHIANG Chen-Yuan MD, MPH, DrPhilos Transmissibility, Virulence and Fitness of resistant strains of M. tuberculosis For infectious
More informationModern lineages of Mycobacterium tuberculosis in Addis Ababa, Ethiopia: implications for the tuberculosis control programe
Modern lineages of Mycobacterium tuberculosis in Addis Ababa, Ethiopia: implications for the tuberculosis control programe * Mihret A 1, 2, 3, Bekele Y 1, Aytenew M 1, Assefa Y 1, Abebe M 1, Wassie L 1,
More informationPATTERNS OF DRUG RESISTANCE AND RFLP ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED FROM RECURRENT TUBERCULOSIS PATIENTS IN SRI LANKA
PATTERNS OF DRUG RESISTANCE AND RFLP ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED FROM RECURRENT TUBERCULOSIS PATIENTS IN SRI LANKA DN Magana-Arachchi 1, AJ Perera 1, V Senaratne 2 and NV Chandrasekharan
More informationDRUG-SENSITIVE AND RESIStant
ORIGINAL CONTRIBUTION Drug-Resistant Tuberculosis, Clinical Virulence, and the Dominance of the Beijing Strain Family in Russia Francis Drobniewski, MD, PhD Yanina Balabanova, MD, PhD Vladyslav Nikolayevsky,
More informationMolecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis
Molecular Epidemiology of Tuberculosis Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis Overview TB transmission and pathogenesis Genotyping methods Genotyping for clinical management
More informationGlobal epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos
Global epidemiology of drug-resistant tuberculosis Factors contributing to the epidemic of MDR/XDR-TB CHIANG Chen-Yuan MD, MPH, DrPhilos By the end of this presentation, participants would be able to describe
More informationDiagnosis of drug resistant TB
Diagnosis of drug resistant TB Megan Murray, MD, ScD Harvard School of Public Health Brigham and Women s Hospital Harvard Medical School Broad Institute Global burden of TB 9 million new cases year 2 million
More informationMycobacterium tuberculosis and Molecular Epidemiology: An Overview
Journal of Microbiology Research 2014, 4(6A): 25-31 DOI: 10.5923/s.microbiology.201401.04 Mycobacterium tuberculosis and Molecular Epidemiology: An Overview Asho Ali Department of Biology, King Abdul Aziz
More informationTuberculosis Elimination, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
ORIGINAL ARTICLE 10.1111/j.1469-0691.2007.01711.x Association of specific mutations in katg, rpob, rpsl and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia
More informationTuberculosis Disparity Between US-born African-Americans and Caucasians in Houston:
Tuberculosis Disparity Between US-born African-Americans and Caucasians in Houston: A population-based study Jose A. Serpa 1, M.D.; Larry D. Teeter 2, Ph.D., James M. Musser 2, M.D., Ph.D. and Edward A.
More informationJillian Dormandy, BS; Akos Somoskovi, MD, PhD; Barry N. Kreiswirth, PhD; Jeffrey R. Driscoll, PhD; David Ashkin, MD; and Max Salfinger, MD
Original Research LUNG INFECTION Discrepant Results Between Pyrazinamide Susceptibility Testing by the Reference BACTEC 460TB Method and pnca DNA Sequencing in Patients Infected With Multidrug-Resistant
More informationDrug Resistant Tuberculosis Biology, Epidemiology and Control Dr. Christopher Dye
Director of Health Information World Health Organization Geneva 1 1. Why TB patients are treated with drugs 2 Natural history and control of TB Fast 5/1 Slow 5/1 Uninfected Latent Active 1 1 infection/case
More informationGlobal Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics
Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Neel R. Gandhi, MD Emory Rollins School of Public Health January 17, 2013 Medical Research Council BMJ 1948
More informationBEIJING GENOTYPE AND OTHER PREDOMINANT MYCOBACTERIUM TUBERCULOSIS SPOLIGOTYPES OBSERVED IN MASHHAD CITY, IRAN
Indian Journal of Medical Microbiology, (2009) 27(4): 306-10 Original Article BEIJING GENOTYPE AND OTHER PREDOMINANT MYCOBACTERIUM TUBERCULOSIS SPOLIGOTYPES OBSERVED IN MASHHAD CITY, IRAN *M Rohani, P
More informationSpoligotyping of Mycobacterium tuberculosis Isolates from Pakistan Reveals Predominance of Central Asian Strain 1 and Beijing Isolates
JOURNAL OF CLINICAL MICROBIOLOGY, May 2006, p. 1763 1768 Vol. 44, No. 5 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.5.1763 1768.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved.
More informationTuberculosis Transmission by Patients with Smear- Negative Pulmonary Tuberculosis in a Large Cohort in The Netherlands
MAJOR ARTICLE Tuberculosis Transmission by Patients with Smear- Negative Pulmonary Tuberculosis in a Large Cohort in The Netherlands Alma Tostmann, 1,2 Sandra V. Kik, 3,4 Nico A. Kalisvaart, 3 Maruschka
More informationMultidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area
Rapid communications Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area C Ködmön (csaba.kodmon@ecdc.europa.eu)
More informationRapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa
Journal of Antimicrobial Chemotherapy Advance Access published October 21, 2008 Journal of Antimicrobial Chemotherapy doi:10.1093/jac/dkn433 Rapid genotypic assays to identify drug-resistant Mycobacterium
More informationMYCOBACTERIUM TUBERCULOSIS GENETIC DIVERSITY AND DRUG RESISTANCE CONFERRING MUTATIONS IN THE DEMOCRATIC REPUBLIC OF THE CONGO
December 2011 Ea s t Af r i c a n Me d i c a l Jo u r n a l 409 East African Medical Journal Vol. 88 No. 12 December 2011 MYCOBACTERIUM TUBERCULOSIS GENETIC DIVERSITY AND DRUG RESISTANCE CONFERRING MUTATIONS
More informationResearch Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant Tuberculosis in Nepal
Hindawi International Scholarly Research Notices Volume 2017, Article ID 1635780, 5 pages https://doi.org/10.1155/2017/1635780 Research Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant
More informationHow Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008
How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008 Today s Outline 1) Global spread of Mtb Comparative genomics Phylogeny 2) Transmission of drug-resistant Mtb Fitness assays Molecular epidemiology
More informationThe proportion of tuberculosis patients coinfected. The association between HIV and antituberculosis drug resistance
Eur Respir J 2008; 32: 718 725 DOI: 10.1183/09031936.00022308 CopyrightßERS Journals Ltd 2008 The association between HIV and antituberculosis drug resistance C.E. French*, J.R. Glynn #, M.E. Kruijshaar*,
More informationThe authors assessed drug susceptibility patterns
Drug Resistance Among Tuberculosis Patients, 1991 and 1992 New York City, CYNTHIA R. DRIVER, RN, MPH THOMAS R. FRIEDEN, MD, MPH ALAN B. BLOCH, MD, MPH IDA M. ONORATO, MD All the authors are with the Division
More informationLeonard V. Sacks, Stella Pendle, Dragana Orlovic, Lucille Blumberg, and Constantinos Constantinou
96 A Comparison of Outbreak- and Nonoutbreak-Related Multidrug-Resistant Tuberculosis Among Human Immunodeficiency Virus Infected Patients in a South African Hospital Leonard V. Sacks, Stella Pendle, Dragana
More informationEmergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
CHEST Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli Original Research Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in Iran Ali Akbar Velayati,
More informationUsefulness of Spoligotyping To Discriminate IS6110 Low-Copy- Number Mycobacterium tuberculosis Complex Strains Cultured in Denmark
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1999, p. 2602 2606 Vol. 37, No. 8 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Usefulness of Spoligotyping To Discriminate
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA January 2016 Summary This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis
More informationIndia accounts for 30% of tuberculosis (TB) cases
Predominant Tuberculosis Spoligotypes, Delhi, India Urvashi Balbir Singh,* Naga Suresh,* N.Vijaya Bhanu,* Jyoti Arora,* Hema Pant,* Sanjeev Sinha,* Ram Charan Aggarwal,* Sushma Singh,* Jitendra Nath Pande,*
More informationMolecular Genotyping of Mycobacterium tuberculosis Isolates from Turkey
American Journal of Infectious Diseases 1 (1): 5-11, 2005 ISSN 1553-6203 Science Publications, 2005 Molecular Genotyping of Mycobacterium tuberculosis Isolates from Turkey 1,2 Berrin Gencer and 1 Thomas
More informationSpread of Drug-Resistant Pulmonary Tuberculosis in Estonia
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2001, p. 3339 3345 Vol. 39, No. 9 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.9.3339 3345.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationBeijing/w and major spoligotype families of Mycobacterium tuberculosis strains isolated from tuberculosis patients in Eastern Turkey
NEW MICROBIOLOGICA, 32, 255-263, 2009 Beijing/w and major spoligotype families of Mycobacterium tuberculosis strains isolated from tuberculosis patients in Eastern Turkey Baris Otlu 1, Riza Durmaz 1, Selami
More informationDepartment of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
Indian J Med Res 135, May 2012, pp 756-762 Variations in the occurrence of specific rpob mutations in rifampicinresistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in
More informationMolecular Epidemiology of Tuberculosis
The new england journal of medicine review article current concepts Molecular Epidemiology of Tuberculosis Peter F. Barnes, M.D., and M. Donald Cave, Ph.D. The standard approach to genotyping M. tuberculosis
More informationEpidemiology and diagnosis of MDR-TB in children H Simon Schaaf
Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Definitions
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationTB 101 Disease, Clinical Assessment and Lab Testing
TB 101 Disease, Clinical Assessment and Lab Testing Pacific Islands Tuberculosis Controllers Association Conference (PITCA) Clinical Laboratory Breakout None Disclosure Objectives Be able to list and explain
More informationRapid detection of multidrug-resistant tuberculosis
Eur Respir J 1997; 10: 1120 1124 DOI: 10.1183/09031936.97.10051120 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 Rapid detection of multidrug-resistant
More informationScott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer
Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Feedback Poll In my opinion, the recent media coverage of
More informationPredictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Eur Respir J 2009; 33: 1085 1094 DOI: 10.1183/09031936.00155708 CopyrightßERS Journals Ltd 2009 Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB K. Kliiman and
More informationGenetic diversity of Mycobacterium tuberculosis isolates from Beijing, China assessed by Spoligotyping, LSPs and VNTR profiles
Lu et al. BMC Infectious Diseases 2012, 12:372 RESEARCH ARTICLE Open Access Genetic diversity of Mycobacterium tuberculosis isolates from Beijing, China assessed by Spoligotyping, LSPs and VNTR profiles
More informationMIRU-VNTR.. (HGI) HunterGaston Discriminatory Index MIRU-VNTR :
- ( ) MIRU- *. :. 12 MIRU- 15 MIRU-. MIRU-. (HGI) HunterGaston Discriminatory Index.( ) : MIRU- QUB11b.(HGI=) QUB26 (HGI /) QUB26. MIRU16. MIRU26 MIRU23 MIRU27 MIRU39 Mtub21.(HGI
More informationSpoligotypes of Mycobacterium tuberculosis from Different Provinces of China
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2010, p. 4102 4106 Vol. 48, No. 11 0095-1137/10/$12.00 doi:10.1128/jcm.00549-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Spoligotypes
More informationThe re-emergence of tuberculosis: what have we learnt from molecular epidemiology?
REVIEW 10.1111/1469-0691.12253 The re-emergence of tuberculosis: what have we learnt from molecular epidemiology? M. W. Borgdorff 1,2 and D. van Soolingen 3,4 1) Department of Infectious Diseases, Public
More informationResponding to a TB Event Bismarck, North Dakota June 24-25, 2008
Responding to a TB Event Bismarck, North Dakota June 24-25, 2008 TB Epidemiology: Global and State Lynelle Phillips, RN, MPH June 24, 2008 TB Epidemiology Global and State Lynelle Phillips RN MPH Nurse
More informationTransmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis
Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis Sofía Samper, Carlos Martín, Alfonso Pinedo*, Antonio Rivero, Jesús Blázquez, Fernando Baquero,
More informationProgress towards tuberculosis elimination: secular trend, immigration and transmission
Eur Respir J 2010; 36: 339 347 DOI: 10.1183/09031936.00155409 CopyrightßERS 2010 Progress towards tuberculosis elimination: secular trend, immigration and transmission M.W. Borgdorff*,#, S. van den Hof
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
SURVEILLANCE REPORT Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA March 2017 Summary This report describes the geographical and temporal distribution of multidrug-resistant
More informationExtensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa Neel R Gandhi, Anthony Moll, A Willem Sturm, Robert Pawinski,
More informationMULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic
MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin
More informationA Two-Step Strategy for Molecular Typing of Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates from Poland
Polish Journal of Microbiology 2011, Vol. 60, No 3, 233 241 ORIGINAL PAPER A Two-Step Strategy for Molecular Typing of Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates from Poland TOMASZ
More informationTB Laboratory for Nurses
TB Laboratory for Nurses Shea Rabley, RN, MN Consultant Mayo Clinic Center for Tuberculosis 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Objectives Participants will be able to: 1. Name 2 safety
More informationFilipa Matos, Mónica V. Cunha*, Ana Canto, Teresa Albuquerque, Alice Amado, and. INRB, I.P./LNIV- Laboratório Nacional de Investigação Veterinária
JCM Accepts, published online ahead of print on 15 September 2010 J. Clin. Microbiol. doi:10.1128/jcm.01762-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationTB & HIV CO-INFECTION IN CHILDREN. Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012
TB & HIV CO-INFECTION IN CHILDREN Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012 Introduction TB & HIV are two of the leading causes of morbidity & mortality in children
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationClinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis
Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis Amit S. Chitnis, MD, MPH; Pennan M. Barry, MD, MPH; Jennifer M. Flood, MD, MPH. California Tuberculosis Controllers
More informationMultidrug resistance after inappropriate tuberculosis treatment: a meta-analysis
Eur Respir J 2012; 39: 1511 1519 DOI: 10.1183/09031936.00125711 CopyrightßERS 2012 ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution SERIES RATIONAL
More informationTransmission of multidrug-resistant tuberculosis in a low-incidence setting, Switzerland, 2006 to 2012
Research articles Transmission of multidrug-resistant in a low-incidence setting, Switzerland, 2006 to 2012 A Somoskovi (asomoskoevi@imm.uzh.ch) 1, P Helbling 2, V Deggim 1, R Hömke 1, C Ritter 1, E C
More informationThe WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps
The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps Matteo Zignol STOP TB Department World Health Organization TB surveillance and
More informationMIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece
Therapeutic Advances in Respiratory Disease Original Research MIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece Nikoletta Rovina, Simona Karabela, Pantelis Constantoulakis, Vassiliki Michou,
More informationCharacterization of Mycobacterium tuberculosis Isolates from Patients in Houston, Texas, by Spoligotyping
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2000, p. 669 676 Vol. 38, No. 2 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Characterization of Mycobacterium tuberculosis
More informationMolecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis
REVIEW 10.1111/j.1469-0691.2011.03577.x Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis W. Sougakoff National Reference Centre for Mycobacteria (CNR-MyRMA), Laboratoire
More informationTuberculosis in South West Centre: Annual review (2014 data) Data from 2000 to 2014
Tuberculosis in South West Centre: Annual review (2014 data) Data from 2000 to 2014 2 About Public Health England Public Health England exists to protect and improve the nation's health and wellbeing,
More informationA ten-year evolution of a multidrugresistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia ( )
A ten-year evolution of a multidrugresistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011) Naira Dekhil 1, Besma Mhenni 1, Raja Haltiti 2, and Helmi Mardassi 1 (speaker)
More informationAnti-tuberculosis drug resistance in the world and rapid diagnosis of tuberculosis
Anti-tuberculosis drug resistance in the world and rapid diagnosis of tuberculosis Chiyoji ABE acquired drug resistance primary drug resistance 10 10 HIV 1 3 INHRFP MDR-TB DOTSDirectly Observed Treatment,
More informationMicrobiological Pathology, Sefako Makgatho Health Science University, Pretoria, South Africa 2
The Incidence of discordant Rifampicin susceptibility results between genotypic and phenotypic methods in Mycobacterium tuberculosis complex isolates at Dr George Mukhari Hospital Tertiary Laboratory,
More informationOUT-TB Web. Ontario Universal Typing of Tuberculosis: Surveillance and Communication System
OUT-TB Web Ontario Universal Typing of Tuberculosis: Surveillance and Communication System Dr. Frances Jamieson, Ontario Public Health Laboratories November 30 th, 2009 Tuberculosis : A Global Problem
More informationTuberculosis transmission in the Netherlands : the role of immigration and travel Kik, S.V.
UvA-DARE (Digital Academic Repository) Tuberculosis transmission in the Netherlands : the role of immigration and travel Kik, S.V. Link to publication Citation for published version (APA): Kik, S. V. (2009).
More informationAssociation of Mycobacterium tuberculosis complex isolates of BOVIS and Central Asian (CAS) genotypic lineages with extrapulmonary disease
ORIGINAL ARTICLE 10.1111/j.1469-0691.2009.02712.x Association of Mycobacterium tuberculosis complex isolates of BOVIS and Central Asian (CAS) genotypic lineages with extrapulmonary disease N. Lari 1, L.
More informationHaiyan Dong, Zhiguang Liu, Bing Lv, Yuanyuan Zhang, Jie Liu, Xiuqin Zhao, Jinghua Liu and
JCM Accepts, published online ahead of print on August 0 J. Clin. Microbiol. doi:./jcm.00- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. 1
More informationDST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps?
DST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps? Mark Nicol Division of Medical Microbiology and Institute for Infectious Diseases and
More informationORIGINAL INVESTIGATION. Reinfection Plays a Role in a Population Whose Clinical/Epidemiological Characteristics Do Not Favor Reinfection
Tuberculosis Recurrences ORIGINAL INVESTIGATION Reinfection Plays a Role in a Population Whose Clinical/Epidemiological Characteristics Do Not Favor Reinfection Darío García de Viedma, PhD; Mercedes Marín,
More informationEpidemiology of drug-resistant tuberculosis among children and adolescents in South Africa
Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa 2005 2010 BK Moore 1, E Anyalechi 1, M van der Walt 2, S Smith 1, L Erasmus 3, J Lancaster 2, S Morris 1, N Ndjeka
More informationA Country-Wide Study of Spoligotype and Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates from Children in China
A Country-Wide Study of Spoligotype and Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates from Children in China Weiwei Jiao 1., Zhiguang Liu 2,3., Rui Han 1., Xiuqin Zhao 2,3, Fang
More informationThe impact of drug resistance on the global tuberculosis epidemic
INT J TUBERC LUNG DIS 4(2):S71 S75 2000 IUATLD The impact of drug resistance on the global tuberculosis epidemic N. W. Schluger The Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia
More informationThe incubation period distribution of tuberculosis estimated with a molecular epidemiological approach
Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 2011; all rights reserved. Advance Access publication 26 March 2011 International Journal of
More information511,000 (57% new cases) ~50,000 ~30,000
Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27
More informationPopulation Structure of Mixed Mycobacterium tuberculosis Infection Is Strain Genotype and Culture Medium Dependent
Population Structure of Mixed Mycobacterium tuberculosis Infection Is Strain Genotype and Culture Medium Dependent Madeleine Hanekom 1 *, Elizabeth M. Streicher 2, Doreen Van de Berg 2, Helen Cox 3, Cheryl
More informationThe New England Journal of Medicine EXOGENOUS REINFECTION AS A CAUSE OF RECURRENT TUBERCULOSIS AFTER CURATIVE TREATMENT
EXOGENOUS REINFECTION AS A CAUSE OF RECURRENT TUBERCULOSIS AFTER CURATIVE TREATMENT ANNELIES VAN RIE, M.D., ROBIN WARREN, PH.D., MADELEINE RICHARDSON, M.SC., THOMAS C. VICTOR, PH.D., ROBERT P. GIE, M.D.,
More informationStrain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients
International Journal of Infectious Diseases (2009) 13, 236 242 http://intl.elsevierhealth.com/journals/ijid Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary
More informationResearch Article Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe
Tuberculosis Research and Treatment, Article ID 349141, 8 pages http://dx.doi.org/10.1155/2014/349141 Research Article Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant
More informationDept. of Hygiene, Microbiology and Social Medicine, Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria 2
Cent Eur J Publ Health 006; 1 (): 168 17 Molecular Epidemiology of Tuberculosis in the Czech Republic, 00: Analysis of M. tuberculosis Complex Isolates Originating from the City of Prague, South Moravia
More informationTransmission of MDR/XDR Tuberculosis in Shanghai. Qian Gao Shanghai Medical College Fudan University
Transmission of MDR/XDR Tuberculosis in Shanghai Qian Gao Shanghai Medical College Fudan University Drug Resistant TB in China The Highest DR-TB Burden Country New TB cases/year Cases with any DR MDR XDR
More informationTuberculosis in Greenland current situation and future challenges
Tuberculosis in Greenland current situation and future challenges Thomsen VØ 1, Lillebaek T 1, Stenz F 2,*. 1 International Reference Laboratory of Mycobacteriology, Statens Serum Institut (SSI), the National
More information2016 Annual Tuberculosis Report For Fresno County
206 Annual Tuberculosis Report For Fresno County Cases Rate per 00,000 people 206 Tuberculosis Annual Report Fresno County Department of Public Health (FCDPH) Tuberculosis Control Program Tuberculosis
More informationFirst Insight into Mycobacterium tuberculosis Epidemiology and Genetic Diversity in Trinidad and Tobago
JCM Accepts, published online ahead of print on 29 April 2009 J. Clin. Microbiol. doi:10.1128/jcm.00535-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationPrevalence of resistance to second-line tuberculosis drug among multidrugresistant tuberculosis patients in Viet Nam, 2011
Original Research Prevalence of resistance to second-line tuberculosis drug among multidrugresistant tuberculosis patients in Viet Nam, 2011 Hoa Binh Nguyen, ab Nhung Viet Nguyen, ac Huong Thi Giang Tran,
More informationOverview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing
Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing 1. Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices 1.1 Overview: Mycobacterial Culture, Identification,
More informationTUBERCULOSIS. Presented By: Public Health Madison & Dane County
TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any
More informationTRADITIONALLY, ACTIVE TUBERculosis
ORIGINAL CONTRIBUTION Clinical and Radiographic Correlates of Primary and Reactivation Tuberculosis A Molecular Epidemiology Study Elvin Geng, MD, MPH Barry Kreiswirth, PhD Joe Burzynski, MD, MPH Neil
More informationQian Gao Fudan University
Qian Gao Fudan University Outline Background & Objectives Genotyping methods Establish the epidemiological field sites Preliminary results of Molecular epidemiology of TB in China Molecular epidemiology
More information4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB
Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people
More informationAnnual Epidemiological Report
Annual Epidemiological Report March 2018 National TB surveillance in Ireland, 2017 Key Facts 321 TB cases were notified to HPSC corresponding to a crude incidence rate (CIR) of 6.7 HSE East reported the
More informationTUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report
TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION 2000 Tuberculosis Control In the WHO Western Pacific Region 2002 Report World Health Organization Office for the Western Pacific Region iii TUBERCULOSIS
More informationSpread of Drug-Resistant Mycobacterium tuberculosis Strains of the Beijing Genotype in the Archangel Oblast, Russia
JOURNAL OF CLINICAL MICROBIOLOGY, June 2002, p. 1930 1937 Vol. 40, No. 6 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.6.1930 1937.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01495.x Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katg: a decade of experience
More informationAnnual Tuberculosis Report Oregon 2007
Annual Tuberculosis Report Oregon 7 Oregon Department of Human Services Public Health Division TB Program April 8 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-7.. page
More information